These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

567 related items for PubMed ID: 8607396

  • 1. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 2. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 3. Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythm.
    Crozier IG, Ikram H, Kenealy M, Levy L.
    Am J Cardiol; 1987 Mar 01; 59(6):607-9. PubMed ID: 3103410
    [Abstract] [Full Text] [Related]

  • 4. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.
    Hopson JR, Buxton AE, Rinkenberger RL, Nademanee K, Heilman JM, Kienzle MG.
    Am J Cardiol; 1996 Jan 25; 77(3):72A-82A. PubMed ID: 8607395
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 6. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 8. Encainide versus flecainide for chronic atrial and junctional ectopic tachycardia.
    Kuck KH, Kunze KP, Schlüter M, Duckeck W.
    Am J Cardiol; 1988 Dec 20; 62(19):37L-44L. PubMed ID: 3144166
    [Abstract] [Full Text] [Related]

  • 9. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 10. Summary of efficacy and safety of flecainide for supraventricular arrhythmias.
    Anderson JL, Jolivette DM, Fredell PA.
    Am J Cardiol; 1988 Aug 25; 62(6):62D-66D. PubMed ID: 3136638
    [Abstract] [Full Text] [Related]

  • 11. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May 25; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

  • 12. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY.
    Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 14. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M, Cullen MT, Casadei G.
    Eur Heart J; 1995 Dec 01; 16(12):1943-51. PubMed ID: 8682031
    [Abstract] [Full Text] [Related]

  • 15. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI, Tronstad A, Oie B, Ohm OJ.
    Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798
    [Abstract] [Full Text] [Related]

  • 16. [Effects of intravenous flecainide acetate in patients with concealed atrioventricular pathway with supraventricular tachycardia].
    Song Y.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec 15; 19(6):361-3, 397. PubMed ID: 1821351
    [Abstract] [Full Text] [Related]

  • 17. [Effects of oral and injectable flecainide in patients with an accessory atrioventricular pathway].
    Fauchier JP, Cosnay P, Rouesnel P, Moquet B, Bonnet P, Scala PJ, Demeyer JF.
    Arch Mal Coeur Vaiss; 1985 Oct 15; 78 Spec No():81-90. PubMed ID: 3938264
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
    Neuss H, Schlepper M.
    Am J Cardiol; 1988 Aug 25; 62(6):56D-61D. PubMed ID: 3136637
    [Abstract] [Full Text] [Related]

  • 19. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ.
    Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397
    [Abstract] [Full Text] [Related]

  • 20. Antiarrhythmic treatment with flecainide (Tambocor). Clinical experience from 107 patients.
    Frandsen F, Pless P, Mickley H, Møller M.
    Acta Cardiol; 1990 Jan 25; 45(5):351-7. PubMed ID: 1704167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.